Burke To Host Information Day For People With COPD Westchester.com COPD Day events will run from 10 am to 4 pm in Burke's Wood Pavilion, Building #7, 785 Mamaroneck Avenue in White Plains. Lectures will cover the topics of ... |
Fatigue-Fighting Tips for COPD Patients COPD For COPD patients, however, it often comes with the territory. Different than ordinary tiredness, fatigue in COPD occurs for a variety of reasons and is ... |
Leaf great Ron Ellis speaks to CAW retirees Newsdurhamregion.com Ron Ellis spoke to retirees with CAW Local 222 about the need to get tested for Chronic Obstructive Pulmonary Disease (COPD), a serious disorder that causes ... and more » |
Asthma Treatment Breakthrough Involves Taste Receptors in Lungs The Epoch Times “They all opened the airway more profoundly than any known drug that we have for treatment of asthma or chronic obstructive pulmonary disease (COPD).” and more » |
Forest Labs says COPD drug meets study goal BusinessWeek Forest Laboratories Inc. and partner Almirall SA said Friday their potential lung condition treatment aclidinium bromide met its key goal in a late-stage ... Almirall, Forest COPD drug misses goal in PhIII studyFierceBiotech Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II ...MarketWatch (press release) Forest and Almirall Plan to File COPD Drug by Mid-2011 Despite Surprising ...Genetic Engineering News Bloomberg -Pharmaceutical Business Review all 34 news articles » |
 AsiaOne | Watch out for COPD: The "lung attack" AsiaOne By COPD Association (Singapore) In Singapore, the number of patients with Chronic Obstructive Pulmonary Disease or COPD aged 65 years and above, ... and more » |
Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II ... MarketWatch (press release) MC) today announced top-line results from ACCORD COPD II, a 12-week Phase III study comparing the efficacy and safety of inhaled aclidinium bromide, ... Forest Labs says COPD drug meets study goalBusinessWeek Forest and Almirall Plan to File COPD Drug by Mid-2011 Despite Surprising ...Genetic Engineering News Almirall, Forest COPD drug misses goal in PhIII studyFierceBiotech BusinessWeek -Pharmaceutical Business Review all 36 news articles » |
Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II ... MarketWatch (press release) MC) today announced top-line results from ACCORD COPD II, a 12-week Phase III study comparing the efficacy and safety of inhaled aclidinium bromide, ... Forest Labs says COPD drug meets study goalBusinessWeek Forest and Almirall Plan to File COPD Drug by Mid-2011 Despite Surprising ...Genetic Engineering News Almirall, Forest COPD drug misses goal in PhIII studyFierceBiotech BusinessWeek -Pharmaceutical Business Review all 36 news articles » |
Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II ... MarketWatch (press release) MC) today announced top-line results from ACCORD COPD II, a 12-week Phase III study comparing the efficacy and safety of inhaled aclidinium bromide, ... Forest Labs says COPD drug meets study goalBusinessWeek Forest and Almirall Plan to File COPD Drug by Mid-2011 Despite Surprising ...Genetic Engineering News Almirall, Forest COPD drug misses goal in PhIII studyFierceBiotech BusinessWeek -Pharmaceutical Business Review all 36 news articles » |
Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II ... MarketWatch (press release) MC) today announced top-line results from ACCORD COPD II, a 12-week Phase III study comparing the efficacy and safety of inhaled aclidinium bromide, ... Forest Labs says COPD drug meets study goalBusinessWeek Forest and Almirall Plan to File COPD Drug by Mid-2011 Despite Surprising ...Genetic Engineering News Almirall, Forest COPD drug misses goal in PhIII studyFierceBiotech Pharmaceutical Business Review all 36 news articles » |